Cell and Gene Therapy Market Research Report By Therapy Type (Cell Therapy, Gene Therapy, Combination Therapy), By Application (Oncology, Genetic Disorders, Cardiovascular Diseases, Infectious Diseases), By End Use (Hospital, Research Institutions, Pharmaceutical Companies, Biotechnology Companies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

1.1. Market Overview

1.2. Key Findings

1.3. Market Segmentation

1.4. Competitive Landscape

1.5. Challenges and Opportunities

1.6. Future Outlook

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the study

2.2.1. Research Objective

2.2.2. Assumption

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value chain Analysis

5.2. Porter's Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. CELL AND GENE THERAPY MARKET, BY THERAPY TYPE (USD BILLION)

6.1. Cell Therapy

6.2. Gene Therapy

6.3. Combination Therapy

7. CELL AND GENE THERAPY MARKET, BY APPLICATION (USD BILLION)

7.1. Oncology

7.2. Genetic Disorders

7.3. Cardiovascular Diseases

7.4. Infectious Diseases

8. CELL AND GENE THERAPY MARKET, BY END USE (USD BILLION)

8.1. Hospital

8.2. Research Institutions

8.3. Pharmaceutical Companies

8.4. Biotechnology Companies

9. CELL AND GENE THERAPY MARKET, BY REGIONAL (USD BILLION)

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. UK

9.2.3. France

9.2.4. Russia

9.2.5. Italy

9.2.6. Spain

9.2.7. Rest of Europe

9.3. APAC

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Malaysia

9.3.6. Thailand

9.3.7. Indonesia

9.3.8. Rest of APAC

9.4. South America

9.4.1. Brazil

9.4.2. Mexico

9.4.3. Argentina

9.4.4. Rest of South America

9.5. MEA

9.5.1. GCC Countries

9.5.2. South Africa

9.5.3. Rest of MEA

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market share Analysis

10.4. Major Growth Strategy in the Cell and Gene Therapy Market

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Cell and Gene Therapy Market

10.7. Key developments and growth strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales and Operating Income

10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES

11.1. Intellia Therapeutics

11.1.1. Financial Overview

11.1.2. Products Offered

11.1.3. Key Developments

11.1.4. SWOT Analysis

11.1.5. Key Strategies

11.2. Roche

11.2.1. Financial Overview

11.2.2. Products Offered

11.2.3. Key Developments

11.2.4. SWOT Analysis

11.2.5. Key Strategies

11.3. Gilead Sciences

11.3.1. Financial Overview

11.3.2. Products Offered

11.3.3. Key Developments

11.3.4. SWOT Analysis

11.3.5. Key Strategies

11.4. AbbVie

11.4.1. Financial Overview

11.4.2. Products Offered

11.4.3. Key Developments

11.4.4. SWOT Analysis

11.4.5. Key Strategies

11.5. Bristol Myers Squibb

11.5.1. Financial Overview

11.5.2. Products Offered

11.5.3. Key Developments

11.5.4. SWOT Analysis

11.5.5. Key Strategies

11.6. Sangamo Therapeutics

11.6.1. Financial Overview

11.6.2. Products Offered

11.6.3. Key Developments

11.6.4. SWOT Analysis

11.6.5. Key Strategies

11.7. AveXis

11.7.1. Financial Overview

11.7.2. Products Offered

11.7.3. Key Developments

11.7.4. SWOT Analysis

11.7.5. Key Strategies

11.8. Celyad

11.8.1. Financial Overview

11.8.2. Products Offered

11.8.3. Key Developments

11.8.4. SWOT Analysis

11.8.5. Key Strategies

11.9. CRISPR Therapeutics

11.9.1. Financial Overview

11.9.2. Products Offered

11.9.3. Key Developments

11.9.4. SWOT Analysis

11.9.5. Key Strategies

11.10. Kite Pharma

11.10.1. Financial Overview

11.10.2. Products Offered

11.10.3. Key Developments

11.10.4. SWOT Analysis

11.10.5. Key Strategies

11.11. Novartis

11.11.1. Financial Overview

11.11.2. Products Offered

11.11.3. Key Developments

11.11.4. SWOT Analysis

11.11.5. Key Strategies

11.12. Regeneron Pharmaceuticals

11.12.1. Financial Overview

11.12.2. Products Offered

11.12.3. Key Developments

11.12.4. SWOT Analysis

11.12.5. Key Strategies

11.13. Spark Therapeutics

11.13.1. Financial Overview

11.13.2. Products Offered

11.13.3. Key Developments

11.13.4. SWOT Analysis

11.13.5. Key Strategies

11.14. Bluebird Bio

11.14.1. Financial Overview

11.14.2. Products Offered

11.14.3. Key Developments

11.14.4. SWOT Analysis

11.14.5. Key Strategies

11.15. Amgen

11.15.1. Financial Overview

11.15.2. Products Offered

11.15.3. Key Developments

11.15.4. SWOT Analysis

11.15.5. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1. LIST OF ASSUMPTIONS

TABLE 2. NORTH AMERICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 3. NORTH AMERICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 4. NORTH AMERICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 5. NORTH AMERICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 6. US CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 7. US CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 8. US CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 9. US CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 10. CANADA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 11. CANADA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 12. CANADA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 13. CANADA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 14. EUROPE CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 15. EUROPE CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 16. EUROPE CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 17. EUROPE CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 18. GERMANY CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 19. GERMANY CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 20. GERMANY CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 21. GERMANY CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 22. UK CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 23. UK CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 24. UK CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 25. UK CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 26. FRANCE CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 27. FRANCE CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 28. FRANCE CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 29. FRANCE CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 30. RUSSIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 31. RUSSIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 32. RUSSIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 33. RUSSIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 34. ITALY CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 35. ITALY CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 36. ITALY CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 37. ITALY CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 38. SPAIN CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 39. SPAIN CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 40. SPAIN CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 41. SPAIN CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 42. REST OF EUROPE CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 43. REST OF EUROPE CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 44. REST OF EUROPE CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 45. REST OF EUROPE CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 46. APAC CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 47. APAC CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 48. APAC CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 49. APAC CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 50. CHINA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 51. CHINA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 52. CHINA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 53. CHINA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 54. INDIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 55. INDIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 56. INDIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 57. INDIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 58. JAPAN CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 59. JAPAN CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 60. JAPAN CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 61. JAPAN CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 62. SOUTH KOREA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 63. SOUTH KOREA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 64. SOUTH KOREA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 65. SOUTH KOREA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 66. MALAYSIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 67. MALAYSIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 68. MALAYSIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 69. MALAYSIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 70. THAILAND CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 71. THAILAND CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 72. THAILAND CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 73. THAILAND CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 74. INDONESIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 75. INDONESIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 76. INDONESIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 77. INDONESIA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 78. REST OF APAC CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 79. REST OF APAC CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 80. REST OF APAC CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 81. REST OF APAC CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 82. SOUTH AMERICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 83. SOUTH AMERICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 84. SOUTH AMERICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 85. SOUTH AMERICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 86. BRAZIL CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 87. BRAZIL CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 88. BRAZIL CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 89. BRAZIL CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 90. MEXICO CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 91. MEXICO CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 92. MEXICO CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 93. MEXICO CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 94. ARGENTINA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 95. ARGENTINA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 96. ARGENTINA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 97. ARGENTINA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 98. REST OF SOUTH AMERICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 99. REST OF SOUTH AMERICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 100. REST OF SOUTH AMERICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 101. REST OF SOUTH AMERICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 102. MEA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 103. MEA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 104. MEA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 105. MEA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 106. GCC COUNTRIES CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 107. GCC COUNTRIES CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 108. GCC COUNTRIES CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 109. GCC COUNTRIES CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 110. SOUTH AFRICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 111. SOUTH AFRICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 112. SOUTH AFRICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 113. SOUTH AFRICA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 114. REST OF MEA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY THERAPY TYPE, 2019-2035 (USD BILLIONS)

TABLE 115. REST OF MEA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 116. REST OF MEA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)

TABLE 117. REST OF MEA CELL AND GENE THERAPY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 118. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL

TABLE 119. ACQUISITION/PARTNERSHIP

LIST OF FIGURES

FIGURE 1. MARKET SYNOPSIS

FIGURE 2. NORTH AMERICA CELL AND GENE THERAPY MARKET ANALYSIS

FIGURE 3. US CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 4. US CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 5. US CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 6. US CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 7. CANADA CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 8. CANADA CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 9. CANADA CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 10. CANADA CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 11. EUROPE CELL AND GENE THERAPY MARKET ANALYSIS

FIGURE 12. GERMANY CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 13. GERMANY CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 14. GERMANY CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 15. GERMANY CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 16. UK CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 17. UK CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 18. UK CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 19. UK CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 20. FRANCE CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 21. FRANCE CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 22. FRANCE CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 23. FRANCE CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 24. RUSSIA CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 25. RUSSIA CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 26. RUSSIA CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 27. RUSSIA CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 28. ITALY CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 29. ITALY CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 30. ITALY CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 31. ITALY CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 32. SPAIN CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 33. SPAIN CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 34. SPAIN CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 35. SPAIN CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 36. REST OF EUROPE CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 37. REST OF EUROPE CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 38. REST OF EUROPE CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 39. REST OF EUROPE CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 40. APAC CELL AND GENE THERAPY MARKET ANALYSIS

FIGURE 41. CHINA CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 42. CHINA CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 43. CHINA CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 44. CHINA CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 45. INDIA CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 46. INDIA CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 47. INDIA CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 48. INDIA CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 49. JAPAN CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 50. JAPAN CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 51. JAPAN CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 52. JAPAN CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 53. SOUTH KOREA CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 54. SOUTH KOREA CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 55. SOUTH KOREA CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 56. SOUTH KOREA CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 57. MALAYSIA CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 58. MALAYSIA CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 59. MALAYSIA CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 60. MALAYSIA CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 61. THAILAND CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 62. THAILAND CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 63. THAILAND CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 64. THAILAND CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 65. INDONESIA CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 66. INDONESIA CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 67. INDONESIA CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 68. INDONESIA CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 69. REST OF APAC CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 70. REST OF APAC CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 71. REST OF APAC CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 72. REST OF APAC CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 73. SOUTH AMERICA CELL AND GENE THERAPY MARKET ANALYSIS

FIGURE 74. BRAZIL CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 75. BRAZIL CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 76. BRAZIL CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 77. BRAZIL CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 78. MEXICO CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 79. MEXICO CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 80. MEXICO CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 81. MEXICO CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 82. ARGENTINA CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 83. ARGENTINA CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 84. ARGENTINA CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 85. ARGENTINA CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 86. REST OF SOUTH AMERICA CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 87. REST OF SOUTH AMERICA CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 88. REST OF SOUTH AMERICA CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 89. REST OF SOUTH AMERICA CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 90. MEA CELL AND GENE THERAPY MARKET ANALYSIS

FIGURE 91. GCC COUNTRIES CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 92. GCC COUNTRIES CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 93. GCC COUNTRIES CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 94. GCC COUNTRIES CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 95. SOUTH AFRICA CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 96. SOUTH AFRICA CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 97. SOUTH AFRICA CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 98. SOUTH AFRICA CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 99. REST OF MEA CELL AND GENE THERAPY MARKET ANALYSIS BY THERAPY TYPE

FIGURE 100. REST OF MEA CELL AND GENE THERAPY MARKET ANALYSIS BY APPLICATION

FIGURE 101. REST OF MEA CELL AND GENE THERAPY MARKET ANALYSIS BY END USE

FIGURE 102. REST OF MEA CELL AND GENE THERAPY MARKET ANALYSIS BY REGIONAL

FIGURE 103. KEY BUYING CRITERIA OF CELL AND GENE THERAPY MARKET

FIGURE 104. RESEARCH PROCESS OF MRFR

FIGURE 105. DRO ANALYSIS OF CELL AND GENE THERAPY MARKET

FIGURE 106. DRIVERS IMPACT ANALYSIS: CELL AND GENE THERAPY MARKET

FIGURE 107. RESTRAINTS IMPACT ANALYSIS: CELL AND GENE THERAPY MARKET

FIGURE 108. SUPPLY / VALUE CHAIN: CELL AND GENE THERAPY MARKET

FIGURE 109. CELL AND GENE THERAPY MARKET, BY THERAPY TYPE, 2025 (% SHARE)

FIGURE 110. CELL AND GENE THERAPY MARKET, BY THERAPY TYPE, 2019 TO 2035 (USD Billions)

FIGURE 111. CELL AND GENE THERAPY MARKET, BY APPLICATION, 2025 (% SHARE)

FIGURE 112. CELL AND GENE THERAPY MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)

FIGURE 113. CELL AND GENE THERAPY MARKET, BY END USE, 2025 (% SHARE)

FIGURE 114. CELL AND GENE THERAPY MARKET, BY END USE, 2019 TO 2035 (USD Billions)

FIGURE 115. CELL AND GENE THERAPY MARKET, BY REGIONAL, 2025 (% SHARE)

FIGURE 116. CELL AND GENE THERAPY MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)

FIGURE 117. BENCHMARKING OF MAJOR COMPETITORS